Sun BioPharma, Inc. announced the appointment of Jennifer K. Simpson, Ph.D., as Chief Executive Officer. Dr. Simpson brings more than two decades of public company executive and fundraising experience in oncology drug development and commercialization to Sun BioPharma, most recently having served as CEO of Delcath Systems, Inc.